# Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal Keratoconjunctivitis

> **NCT01751126** · PHASE3 · COMPLETED · sponsor: **Santen SAS** · enrollment: 169 (actual)

## Conditions studied

- Vernal Keratoconjunctivitis

## Interventions

- **DRUG:** NOVA22007 ''Ciclosporin''
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01751126
- **Lead sponsor:** Santen SAS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04-29
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 169 (ACTUAL)
- **Last updated:** 2022-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01751126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01751126, "Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal Keratoconjunctivitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01751126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*